In terms of concomitant cardiac medications, the two arms were well balanced (statins [95% of participants], angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, anti-platelet, anti-coagulation, diabetes medications, calcium channel blockers, diuretics, anti-anginal, and nonsteroidal anti-inflammatory drugsNSAIDs), though the placebo arm had more participants on beta-blockers (49% vs 33%) and fewer participants on alpha-blockers (7% vs 12%)
Studies focusing on semaglutide use in menopausal patients have shown promising results, with many women experiencing weight loss within the first 3-6 months of treatment
Montoyo HP, Vaccaro C, Hafner M, Ober RJ, Mueller W, Ward ES
Im qualified to research and write about GLP-1 medications because I understand the type of care required for people taking these medications
Most side effects are mild and temporary, but vigilance for signs of serious reactions is crucial